Literature DB >> 9369482

The role of HNF1alpha, HNF3gamma, and cyclic AMP in glucose-6-phosphatase gene activation.

B Lin1, D W Morris, J Y Chou.   

Abstract

The gene for glucose-6-phosphatase (G6Pase), the key enzyme in glucose homeostasis, is expressed in a tissue-specific manner in the liver and kidney. To understand the molecular mechanisms regulating liver-specific expression of the G6Pase gene, we characterized G6Pase promoter activity by transient expression assays. The G6Pase promoter is active in HepG2 hepatoma cells, but inactive in JEG3 choriocarcinoma or 3T3 cells. DNA elements essential for optimal and liver-specific expression of the G6Pase gene were contained within nucleotides -234 to +3. Deletion analysis revealed that the G6Pase promoter contained three activation elements (AEs) at nucleotides -234 to -212 (AE-I), -146 to -125 (AE-II), and -124 to -71 (AE-III). AE-I contains binding sites for hepatocyte nuclear factors (HNF) 1 and 4. Electromobility shift and cotransfection assays demonstrated that HNF1alpha, but not HNF4, bound to its cognate site and transactivated G6Pase gene expression. The G6Pase promoter contained five HNF3 motifs, 1 (-180/-174), 2 (-139/-133), 3 (-91/-85), 4 (-81/-75), and 5 (-72/-66), and all five sites bound HNF3gamma with high affinity. Transient expression and cotransfection assays showed that HNF3 site 1 is not required for basal promoter activity, but is essential for HNF3gamma-activated transcription from the G6Pase promoter. We further showed that HNF3 sites 3, 4, and 5 were essential for basal G6Pase promoter activity and transactivation by HNF3gamma. AE-II contains, in addition to a HNF3 motif, a cAMP-response element (CRE) and a C/EBP half-site. The G6Pase(-146/-116) DNA containing AE-II formed multiple protein-DNA complexes with HepG2 nuclear extracts, including HNF3gamma, CRE-binding protein (CREB), C/EBPalpha, and C/EBPbeta. We showed that AE-II mediated transcription activation of the G6Pase gene by cAMP.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9369482     DOI: 10.1021/bi9703249

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  29 in total

1.  Differential regulation of gene expression by insulin and IGF-1 receptors correlates with phosphorylation of a single amino acid residue in the forkhead transcription factor FKHR.

Authors:  J Nakae; V Barr; D Accili
Journal:  EMBO J       Date:  2000-03-01       Impact factor: 11.598

2.  Elevated levels of hepatocyte nuclear factor 3beta in mouse hepatocytes influence expression of genes involved in bile acid and glucose homeostasis.

Authors:  F M Rausa; Y Tan; H Zhou; K W Yoo; D B Stolz; S C Watkins; R R Franks; T G Unterman; R H Costa
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

3.  Characterization of the human liver fructose-1,6-bisphosphatase gene promoter.

Authors:  B Herzog; M Waltner-Law; D K Scott; K Eschrich; D K Granner
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

4.  In search of proof-of-concept: gene therapy for glycogen storage disease type Ia.

Authors:  Dwight D Koeberl
Journal:  J Inherit Metab Dis       Date:  2012-02-07       Impact factor: 4.982

5.  Hepatorenal correction in murine glycogen storage disease type I with a double-stranded adeno-associated virus vector.

Authors:  Xiaoyan Luo; Gentzon Hall; Songtao Li; Andrew Bird; Peter J Lavin; Michelle P Winn; Alex R Kemper; Talmage T Brown; Dwight D Koeberl
Journal:  Mol Ther       Date:  2011-07-05       Impact factor: 11.454

6.  Complete normalization of hepatic G6PC deficiency in murine glycogen storage disease type Ia using gene therapy.

Authors:  Wai Han Yiu; Young Mok Lee; Wen-Tao Peng; Chi-Jiunn Pan; Paul A Mead; Brian C Mansfield; Janice Y Chou
Journal:  Mol Ther       Date:  2010-04-13       Impact factor: 11.454

7.  The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression.

Authors:  J Nakae; T Kitamura; D L Silver; D Accili
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

8.  Interleukin-6-induced STAT3 and AP-1 amplify hepatocyte nuclear factor 1-mediated transactivation of hepatic genes, an adaptive response to liver injury.

Authors:  J I Leu; M A Crissey; J P Leu; G Ciliberto; R Taub
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

9.  Hepatocyte nuclear factor-1 acts as an accessory factor to enhance the inhibitory action of insulin on mouse glucose-6-phosphatase gene transcription.

Authors:  R S Streeper; E M Eaton; D H Ebert; S C Chapman; C A Svitek; R M O'Brien
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

10.  STAT3 targets the regulatory regions of gluconeogenic genes in vivo.

Authors:  Preeti Ramadoss; Nathan E Unger-Smith; Francis S Lam; Anthony N Hollenberg
Journal:  Mol Endocrinol       Date:  2009-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.